Qube Research & Technologies LTD Rocket Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

$93.8 Billion
Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,548,262 shares of RCKT stock, worth $5.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,548,262

Previous 195,793 690.76%

Holding current value

$5.09 Million

Previous $1.31 Million 190.65%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.33 - $8.01 $3.15 Million - $10.8 Million	1,352,469 Added 690.76%	1,548,262 $3.79 Million
Q1 2025 May 15, 2025	BUY	$6.67 - $12.72 $1.31 Million - $2.49 Million	195,793 New	195,793 $1.31 Million
Q1 2024 May 14, 2024	BUY	$26.16 - $30.74 $4.64 Million - $5.46 Million	177,524 New	177,524 $4.78 Million
Q3 2023 Nov 13, 2023	SELL	$15.07 - $24.05 $2.11 Million - $3.37 Million	-139,994 Reduced 52.46%	126,862 $2.6 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $2.79 Million - $3.97 Million	168,207 Added 170.51%	266,856 $5.3 Million
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $1.56 Million - $2.23 Million	98,649 New	98,649 $1.69 Million
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $187,776 - $392,537	23,590 Added 75.26%	54,935 $756,000
Q1 2022 May 09, 2022	BUY	$13.16 - $23.68 $39,861 - $71,726	3,029 Added 10.7%	31,345 $497,000
Q4 2021 Feb 01, 2022	BUY	$21.52 - $36.02 $609,360 - $1.02 Million	28,316 New	28,316 $618,000
Q2 2021 Aug 13, 2021	SELL	$39.41 - $47.25 $537,946 - $644,962	-13,650 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$43.34 - $65.91 $591,591 - $899,671	13,650 New	13,650 $606,000
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $105,120 - $271,840	-10,826 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$11.07 - $24.23 $119,843 - $262,313	10,826 New	10,826 $246,000

Others Institutions Holding RCKT

# of Institutions

219

Shares Held

98.3M

Call Options Held

608K

Put Options Held

474K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $249M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Rocket Pharmaceuticals, Inc. Transaction History